Volume 21, Issue 5
Meet the Our Co Editor
Pp: 1023-1023
Author(s): Filippo Caraci
DOI: 10.2174/1570159X2105230320095212
Mitochondrial Medicine for Neurological Disorders
Pp: 1024-1025
Author(s): Md. Sahab Uddin, Badrah S. Alghamdi and Ghulam Md. Ashraf
DOI: 10.2174/1570159X2105230320095644
Pharmacological Progress of Mitophagy Regulation
Pp: 1026-1041
Author(s): Sheikh Arslan Sehgal*, Hao Wu, Muhammad Sajid, Summar Sohail, Muhammad Ahsan, Gulnaz Parveen, Mehreen Riaz, Muhammad Saleem Khan, Muhammad Nasir Iqbal and Abbeha Malik
DOI: 10.2174/1570159X21666230314140528
Treatment of Autism Spectrum Disorders by Mitochondrial-targeted Drug: Future of Neurological Diseases Therapeutics
Pp: 1042-1064
Author(s): Showkat Ul Nabi, Muneeb U. Rehman*, Azher Arafah, Syed Taifa, Iqra Shafi Khan, Andleeb Khan*, Summya Rashid, Fatimah Jan, Hilal Ahmad Wani and Sheikh Fayaz Ahmad
DOI: 10.2174/1570159X21666221121095618
The Role of Mitochondria-Targeting miRNAs in Intracerebral Hemorrhage
Pp: 1065-1080
Author(s): Ilgiz Gareev, Ozal Beylerli*, Yanchao Liang, Enzhou Lu, Tatiana Ilyasova, Albert Sufianov, Galina Sufianova, Huaizhang Shi, Aamir Ahmad* and Guang Yang*
DOI: 10.2174/1570159X20666220507021445
Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
Pp: 1081-1099
Author(s): Md. Mominur Rahman, Afroza Alam Tumpa, Md. Saidur Rahaman, Fahadul Islam, Popy Rani Sutradhar, Muniruddin Ahmed, Badrah S. Alghamdi, Abdul Hafeez, Athanasios Alexiou*, Asma Perveen and Ghulam Md. Ashraf*
DOI: 10.2174/1570159X21666230316150559
The Therapeutic Potential of Mitochondria Transplantation Therapy in Neurodegenerative and Neurovascular Disorders
Pp: 1100-1116
Author(s): Mohammad Moshahid Khan*, Hector G. Paez, Christopher R. Pitzer and Stephen E. Alway
DOI: 10.2174/1570159X05666220908100545
Boosting Mitochondrial Potential: An Imperative Therapeutic Intervention in Amyotrophic Lateral Sclerosis
Pp: 1117-1138
Author(s): Swati Dhasmana, Anupam Dhasmana, Sudhir Kotnala, Varsha Mangtani, Acharan S. Narula, Shafiul Haque, Meena Jaggi, Murali M. Yallapu and Subhash C. Chauhan*
DOI: 10.2174/1570159X20666220915092703
What Happens in TBI? A Wide Talk on Animal Models and Future Perspective Satyabrata
Pp: 1139-1164
Author(s): Satyabrata Kundu and Shamsher Singh*
DOI: 10.2174/1570159X20666220706094248
Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders
Pp: 1165-1183
Author(s): Mohannad A. Almikhlafi, Mohammed M. Karami, Ankit Jana, Thamer M. Alqurashi, Mohammed Majrashi, Badrah S. Alghamdi and Ghulam Md. Ashraf*
DOI: 10.2174/1570159X20666220830112408
Resveratrol-Mediated Regulation of Mitochondria Biogenesis-associated Pathways in Neurodegenerative Diseases: Molecular Insights and Potential Therapeutic Applications
Pp: 1184-1201
Author(s): Abdullah Shaito, Maryam Al-Mansoob, Salma M.S. Ahmad, Mohammad Z. Haider, Ali H. Eid, Anna Maria Posadino, Gianfranco Pintus* and Roberta Giordo
DOI: 10.2174/1570159X20666221012122855
Noncoding RNAs: Novel Targets for Opioid Tolerance
Pp: 1202-1213
Author(s): Meiling Deng and Wangyuan Zou*
DOI: 10.2174/1570159X21666221129122932
Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson’s Disease: Beyond the Primary Mechanism of Action
Pp: 1214-1223
Author(s): Domiziana Rinaldi, Marika Alborghetti, Edoardo Bianchini, Michela Sforza, Silvia Galli and Francesco E. Pontieri*
DOI: 10.2174/1570159X20666220905102144
Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease
Pp: 1224-1240
Author(s): Xiao-Zhong Jing, Hui-Jia Yang, Reyisha Taximaimaiti and Xiao-Ping Wang*
DOI: 10.2174/1570159X20666220915091022
Selecting the Best Animal Model of Parkinson’s Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies
Pp: 1241-1272
Author(s): Caroline Cristiano Real, Karina Henrique Binda, Majken Borup Thomsen, Thea Pinholt Lillethorup, David James Brooks and Anne Marlene Landau*
DOI: 10.2174/1570159X21666230216101659
Melatonin as a Harmonizing Factor of Circadian Rhythms, Neuronal Cell Cycle and Neurogenesis: Additional Arguments for Its Therapeutic Use in Alzheimer’s Disease
Pp: 1273-1298
Author(s): Mayuri Shukla and Bruno Vincent*
DOI: 10.2174/1570159X21666230314142505
